WS #9250

The dominant signal in this window is a major escalation in the Iran-Israel conflict. Iran has launched ballistic missiles and Shahed-136 drones at Israel, with reports of multiple waves and impacts in northern Israel, including near Haifa and the Ramat David airbase. The IRGC confirmed the attack as retaliation for an Israeli strike on Beirut, which violated a fragile US-brokered ceasefire. Israel's military chief stated the IDF will strike 'the enemy' with determination once ordered, and the US Embassy in Jerusalem ordered shelter-in-place. Trump reportedly urged Netanyahu to delay action for a potential diplomatic deal, but also held a phone call with Netanyahu after the attack. The Strait of Hormuz blockade and oil price surge narrative is reinforced by GDELT reports of US CENTCOM downing Iranian drones in the strait and oil projected past $115. This escalation is a significant negative for risk assets (SPY, QQQ) and bullish for energy (XOM, CVX, XLE) and defense (LMT, NOC). The Iran-Israel narrative is ESCALATING. Separately, a low-signal item: Pfizer's VESPER-1 trial showed nearly 16% weight loss at 32 weeks on berobenatide, which is a positive for PFE but not yet corroborated by major outlets. The previous situational awareness noted no new developments, but this window contains a clear escalation.